Akebia Therapeutics Inc. buy SVB Leerink LLC
Start price
28.04.25
/
50%
€2.08
Target price
28.04.26
€6.16
Performance (%)
-44.91%
Price
06.02.26
€1.15
Summary
This prediction is currently active. Massive losses of -44.91% have been the result for the BUY prediction by SVB_Leerink_LLC. This prediction currently runs until 28.04.26. The prediction end date can be changed by SVB_Leerink_LLC at any time. SVB_Leerink_LLC has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| Akebia Therapeutics Inc. | -2.956% | -2.956% |
| iShares Core DAX® | 1.085% | -0.846% |
| iShares Nasdaq 100 | -1.665% | -3.306% |
| iShares Nikkei 225® | 3.863% | 6.308% |
| iShares S&P 500 | 0.111% | -1.337% |
Comments by SVB_Leerink_LLC for this prediction
In the thread Akebia Therapeutics Inc. diskutieren
Akebia Therapeutics, Inc. (NASDAQ: AKBA) is now covered by analysts at Leerink Partners. They set an "outperform" rating and a $7.00 price target on the stock.
Ratings data for AKBA provided by MarketBeat